TipRanks
Protagonist Therapeutics (DE:PGF)
BERLIN:PGF

Compare Protagonist Therapeutics (PGF) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Protagonist Therapeutics
€75.00
€8.06B
116.46
35.14%
12 Buy
0 Hold
0 Sell
Strong Buy
Aurinia Pharmaceuticals
$16.75
$2.19B
6.97
27.94%
2 Buy
1 Hold
0 Sell
Moderate Buy
Spyre Therapeutics
$107.36
$7.56B
-43.94
448.94%
11 Buy
1 Hold
0 Sell
Strong Buy
Immunovant
$43.82
$6.88B
-11.81
112.51%
8 Buy
3 Hold
0 Sell
Moderate Buy
Vera Therapeutics
$35.28
$2.34B
-5.55
20.70%
11 Buy
1 Hold
0 Sell
Strong Buy
Abivax SA Sponsored ADR
$116.52
$8.15B
-17.39
11.05%
9 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:PGF
Protagonist Therapeutics
75.00
19.50
35.14%
AUPH
Aurinia Pharmaceuticals
16.44
5.38
48.64%
SYRE
Spyre Therapeutics
85.69
69.33
423.78%
IMVT
Immunovant
33.30
17.24
107.35%
VERA
Vera Therapeutics
32.54
3.64
12.60%
ABVX
Abivax SA Sponsored ADR
91.06
7.73
9.28%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts